Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) lost profits on its latest quarterly results, disappointing over-optimistic forecasters. Earnings were poorly sub-par, with returns of $ 6. 5 meters is 62% less than expected. On the other hand, losses increased by $ 2. 50 statutory loss per share is about 11% larger than analysts expected. This is an important time for investors, as they can track the company’s performance in its report, look at what experts are expecting for the next year, and see if there has been any change in the business expectations.. So we’ve rounded up the latest post-profit legal consensus estimate to see what could be in store for the next year.
Taking into account the latest results, 15 analysts at Norwegian Cruise Line Holdings are currently expecting revenues in 2021 to be $ 2. 74b, roughly in line with the past 12 months. The stock loss is expected to decrease significantly in the near future, shrinking 62% to $ 5 USD. 11. Prior to this earnings announcement, analysts were designing a return of $ 2. 79b and a loss of $ 5. 44 per share in 2021. So it appears that there has been a moderate rise in analyst sentiment with the latest release of consensus, given the upgrade to loss per share forecast for next year..
These new estimates raised the target price level by 10. 0% to $ 20 USD. At 31, with lower expected losses indicating that matters may be expected for Norwegian Cruise Line Holdings. This is not the only conclusion we can draw from this data, as some investors also like to take into account the difference in estimates when evaluating analyst price targets.. . Currently, most bullish analysts estimate Norwegian Cruise Line Holdings at $ 26. 00 per share, while the lowest prices are $ 12. 00. This is a fairly wide spread of estimates, which indicates that analysts are anticipating a wide range of potential business outcomes.
Taking a look at the bigger picture now, one way we can understand these forecasts is to see how they compare to both past performance and industry growth projections.. These estimates indicate that sales are expected to slow down, with a projected decrease in revenue of 0. 3%, down significantly from the annualized growth of 4%. 3% over the past five years. By contrast, our data indicates that other companies (with analyst coverage) in the same industry are expected to see their revenues grow 23% annually for the foreseeable future.. It is quite clear that Norwegian Cruise Line Holdings’ revenue is expected to perform much worse than the wider industry.
The most obvious conclusion is that analysts have not made any changes to their forecasts for next year’s loss. Fortunately, analysts also confirmed their revenue estimates, indicating that sales were in line with expectations – although our data indicates that Norwegian Cruise Line Holdings’ revenue is expected to perform worse than the wider industry.. . We note an upgrade to target price, which indicates that analysts believe that the intrinsic value of the business is likely to improve over time..
With this in mind, we still believe that the long-term business path is much more important for investors to consider. At Simply Wall St we have a full suite of analyst estimates for Norwegian Cruise Line Holdings through 2024, and you can see them for free on our platform here.. .
Additionally, you should also familiarize yourself with the three warning signs we spotted with Norwegian Cruise Line Holdings (including 1 which is important) .
This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any shares, nor does it take into account your objectives or financial condition. We aim to provide you with long-term focused analysis driven by fundamental data. Note that our analysis may not include the company’s most recent ads that are price-sensitive or generic. Wall Street simply has no position in any of the listed stocks. Do you have notes on this article? Worried about the content? Contact us directly. Alternatively, email the editor @ simplewallst. Com.
Nio’s ES6 hatchback model faces an imminent threat from potential price cuts for the Tesla Model Y in China, Citron-owned Andrew Left said in an investor note.. Nio did not respond to a request for comment. Tesla has lowered prices in China on several occasions, aiming to gain a greater market share in the world’s largest auto market.
Chinese electric car maker Li Auto rose by as much as 25% during Friday morning’s session after reporting outperforms in its first quarterly results since it was released to the public..
Tesla Inc (NASDAQ: TSLA) CEO Elon Musk said he conducted four tests for COVID-19 on Thursday, two of which came back positive. What happened: Musk said on Twitter that something « very fake is happening » while he tested for COVID-19 four times. “Two tests came back negative, and two came back positive. Same machine, same test, same nurse. « The billionaire businessman said he underwent rapid antigen tests from Becton Dickinson & Co.. (NYSE: BDX). Typical cold symptoms. Nothing extraordinary yet. >> – Elon Musk (@elonmusk) November 13, 2020 The CEO also said on social media that he was choosing to run the polymerase chain reaction (PCR) tests from another lab and that it would take 24 hours to get the results. > If this happens to me, it happens to others. I obtain PCR tests from separate laboratories. The results will take approximately 24 hours. >> – Elon Musk (@elonmusk) November 13, 2020 Musk agreed with a Twitter user who assumed that the proceeds from the tests were « likely not spurious [and] very consistent. Why it matters: Musk has called for an end to lockdowns by tweeting « FREE AMERICA NOW » amid the pandemic. He had argued in favor of reopening the economy with « proper sponsorship [and] protection » and equated closure with house arrest. Managers at the Tesla plant in Fremont, California asked some employees to return to work in April despite infringing health orders prevalent in the area.. In March, Musk wrote on Twitter that children were « basically immune » to COVID-19, prompting Twitter Inc (NYSE: TWTR) to argue about not removing the post, The Verge reported.. Price Action: Tesla shares closed roughly 1. 30% less at $ 411. 76 on Thursday and fell 0. 18% in an after-hours session. See more of Benzinga * Click here for option deals from Benzinga * The China-made Y Model from Tesla threatens Nio’s growing dominance, Bloomberg analysts say * Rivian says all of its electric vehicles will now come with the 2020 Benzinga driver assistance system (C). Com. Benzanga does not provide investment advice. All rights reserved.
The massive rally in electric vehicle stocks in China slowed sharply after Citron Research targeted short sellers Nio.
Tesla Inc (NASDAQ: TSLA) is currently building Gigafactory Texas, which will build Tesla’s Cybertruck, Model 3, Y and maybe more.. The new drone images show the progress of the plant. In a video, the photographer notes some of the many changes observed on the site. Here are some more photos from November 12 in Giga Texas . . . A lot is happening all over the job site! Check out my YouTube video (JoeTegtmeyer) later today for more and more information on what’s going on with the site! Pic. Twitter. com / M75jzDNTnq >> – Joe Tegtmeyer (@JoeTegtmeyer) November 12, 2020 We are starting to see many structures starting to take shape. Most of the vast area of land has been prepared, including more permanent work areas and lots of gravel and backfill for future construction.. Tesla plans to start delivery of the Cybertruck by the end of 2021. Image courtesy of Tesla See more from Benzinga * Click here for deal options from Benzinga * Tesla Gigafactory Shanghai production rate points for annual increase * Waymo suggests « more advanced volume orders » from Tesla’s approach to fully autonomous driving (C) 2020 Benzinga. Com. Benzanga does not provide investment advice. All rights reserved.
The President-elect’s plan would create 401 (k) tax credits for every dollar saved, leveling the playing field by offering the same incentive to provide retirement regardless of worker income. Experts doubt it will move as it is.
There is a clear conclusion that can be drawn from the US election results – the American people wanted to do away with the drama of both President Trump and the Democratic Party, and they are willing to do so by installing a Democratic president as Republicans gain power in Congress and below the ballot.. A result like this indicates a stalemate in the future, at least in the near term, which in turn could be exactly what those markets want.. A deeply divided government is unlikely to make any drastic changes in policy, to the right or left, allowing the financial world to continue to weigh down straight.. . Which means we could be near the bottom for many stocks with lower equity values. If so, this effect may be more pronounced among the so-called penny stocks, which are stocks that sell less than $ 5.. These stocks are already close to the true bottom of the market, and fundamental statistics show that they are more likely than not going higher. However, before jumping right into investing in a penny stock, Wall Street professionals advise looking at the bigger picture and looking at other factors beyond just price.. For some of the names that fall into this category, you really get what you pay for, and offer very few long-term growth opportunities thanks to weak fundamentals, recent headwinds, or even large hanging equity stakes.. With risk in mind, we used TipRanks’ database to find physical stocks with good price tags. The platform directed us towards two indices with stock prices below $ 5 and « strong buy » consensus ratings from the analyst community. Not to mention the possibility of a huge rise on the table. Sequans Communications (SQNS) Sequans Communications is a chipset manufacturer with a strong reputation in the 4G market and a forward-looking focus on the 5G and IoT sectors.. The company has incorporated several generations of technological advances into its IoT chip designs, and has become a leading innovator in this market.. So far, the chaotic conditions of 2020 have not been easy for SQNS. The company has been hit hard by disruptions in supply and distribution chains, and is down 48% since it peaked in July. On the positive side of the ledger, revenues are up – as they have been throughout the year. The highest streak in the third quarter was $ 14. Million, which is a 15 percent increase over the previous quarter and a staggering 116 percent year-on-year. It is currently running for $ 4. 09 per share, Sequans stocks could see significant gains, according to some analysts. By covering Roth Capital stocks, 5-star analyst Scott Searle pointed to the company’s upbeat potential: “Sequans continues to achieve major milestones in developing major clients and products. The company is putting the company on track to obtain samples in late 2021. Most importantly, in addition to the anticipated $ 10 million 5G strategic opportunity, Sequans is actively working with many additional potential partners.. We believe the company is still uniquely positioned to become a Tier 1 supplier in specialized 5G applications which we expect to represent 10 million units by the 2023-2025 timeframe in FWA Ground, Satellite, Public Safety, etc.. . We highlight that Ericsson continues to expect FWA lines to increase from 51 million in 2019 to 160 million by 2025, which represents $ 500 million to $ 1 billion in full.. . To this end, Searle rates SQNS a Buy with a price of $ 13. If his thesis is successful, there could be a potential 218% profit in the cards. (To see Searle’s record, click here) Sequans holds a unanimous strong buy rating from analyst consensus, based on 4 buy reviews submitted in the past two months.. Moreover, the average target price indicates that it will double 148% from current levels. (See SQNS inventory analysis on TipRanks) Repro-Med Systems (KRMD) next on the list, Repro-Med Systems, is a medical device company.. This small-cap company is competitive – but has a high profit potential when new treatments or devices are approved.. KRMD designs products for infusion treatments and emergency medicine, two vital sectors of the medical market. The company operates under the name KORU Medical Systems. KRMD peaked this year in April, and has lost ground in equity value ever since. The stock is down 69%, despite revenue growth in the first half of 2020. Third-quarter results were mixed. The top streak has steadily decreased to just over $ 6 million, but cumulative sales for the first three quarters of 2020 are up 19% over the same period in 2019.. Operating expenses remained stable, and gross profit was more than 64% of net sales. The company ended the quarter with $ 32. 4 million in net cash available. Kyle Rose, a five-star analyst at Canaccord, sees an opportunity here, especially for investors willing to take some risks.. He writes, “For investors who can play these little names, we see this as a compelling buying opportunity. Headwinds in the third quarter are a challenge in the near term but a far cry from changing the thesis in the long term. We still believe that investors will need to look at previous quarterly / quarterly fluctuations to ascertain long-term annual trends, which still look positive here.. KRMD takes advantage of the ongoing trend away from IV delivery to SC Ig and provides a compelling value proposition that sets the company to emerge as the standard of care for the delivery of subcutaneous drugs in large quantities.. Aware of headwinds, Rose listed KRMD to buy along with a $ 10 target price.. This number indicates strong growth of 164% in the coming year. (To view Rose’s record, click here) This is another stock with strong consensus buying from analysts. This rating is based on 3 purchase ratings, and indicates Wall Street confidence. The average share price is $ 9. 67, indicating a 155% rise from the $ 3 trading price. 83. (See KRMD stock analysis at TipRanks) To find good ideas for trading small stocks with attractive valuations, visit Best Stocks to Buy from TipRanks, a newly launched tool that unites all the stock insights for TipRanks. Disclaimer: The opinions expressed in this article are only those of featured analysts. The content is intended for informational use only. It is very important to do your analysis before making any investment.
Chinese President Xi Jinping personally made the decision to suspend the initial public offering of Alibaba Group Holding (NYSE: BABA), which has been billed as the largest initial public offering in the world, according to the Wall Street Journal report.. . What happened: Ant Group could have raised $ 37 billion in its dual listing in China and Hong Kong, valuing the financial services company at more than $ 280 billion, but Chinese regulators have suspended the listing, citing tighter regulations to protect the financial interests of consumers and investors.. The new regulations will force Ant Group to reformulate its business model of being a bridge between borrowers and banks. If all the rules are implemented, it will require Ant to raise more capital to support the loans it gives to clients and seek national licenses to continue its operations.. Reportedly, Alibaba founder Jack Ma infuriated the organizers in his October speech. 24, as he criticized the Chinese government for strict financial regulations and impeding technological development. Ma said he wanted to help solve China’s financial problems through innovation. Xi and other senior leaders, who had read the government’s reports on the speech, were furious. Xi has reportedly ordered Chinese regulators to investigate and possibly close the IPO. Why it matters: The problems between the growing influence of wealthy businessmen in China and the country are not new. “Nothing really cares about whether or not I made any of those rich lists. What he cares about is what you do after you get rich, and whether you align your interests with the interests of the country, ”a Chinese official said, according to the newspaper.. . Ant Alipay’s mobile payment system is used by nearly 70% of the Chinese population, disrupting the financial system. Ant preferred service companies and small businesses that it ignored the traditional banking system and provided loans to more than 20 million small businesses and nearly half a billion individuals.. Reportedly, the regulators wanted to rein in Ant as long as it was spared the strict regulations and capital requirements that commercial banks would have to adhere to.. Some analysts expect Ant’s value to halve to $ 140 billion due to the IPO suspension and new regulations. Image courtesy: Wikimedia See more from Benzinga * Click here for option deals from Benzinga * These tech giants will bear the brunt of China’s antitrust rules, as Bear Morgan Stanley * another Alibaba-backed grocer suffers a massive data breach (C) 2020 Benzinga. Com. Benzanga does not provide investment advice. All rights reserved.
Income investors can still look to the financials. Bank stocks have been hit particularly hard in 2020 by the pandemic, as major exchange-traded funds such as the $ 17 billion SPDR Financial Sector Fund (stock symbol: XLF) have fallen more than 10% this year even as the S&P 500 is moving around 10% higher. Over the past 11 months or so. For the most part, these are modest, trade-focused banks that do not take significant investment risks or other complex operations.
Additionally, I had to pay large sales commissions (my grandson calls them « loads ») when I first bought this money. If I had put all of my money in just one company, I would have received a discount on sales commissions. Finally, her company charges me a « management fee » every three months; My grandson says her company is heavily compensated for by mutual funds, and these fees are actually twice the cost.
The Dow plunged after Mitch McConnell threw cold water in hopes of getting a bigger stimulus bill. Meanwhile, Warren Buffett’s stock has crossed a buyout point.
(Bloomberg) – Stock rally ignited by Pfizer. The results of promising Covid-19 vaccine trials have boosted the fortunes of many investors, but nothing massively like a pair of German brothers. Andreas and Thomas Strongman have collectively added about $ 8 billion to their fortunes this year thanks to their stake in BioNTech SE, the German company developing the vaccine with Pfizer.. BioNTech’s US filing yields rose this week after the U. s. The pharmaceutical giant reports that the shot they are working on prevented 90% of symptomatic infections in tens of thousands of volunteers.. At $ 22 billion, the twins enjoy one of the world’s largest healthcare fortunes, according to the Bloomberg Billionaires Index.. The 70-year-old brothers formed their empire by reinvesting proceeds from generic pharmaceutical companies for their family.. « They have reshaped their fortunes simply by believing in science, » said Paul Westal, co-founder of the family office’s recruitment firm, Agrius Group.. . The Citroingmans did not respond to requests for comment. The brothers set up their family office, Athos Service, shortly after Novartis AG announced in 2005 that it would purchase their pharmaceutical company, Hexal, along with their stake in the affiliate EON Labs for 5. 7 billion euros ($ 6. 7000000000). Thomas Stringmann said in a December interview with the German newspaper Handelsblatt that the two brothers initially promised themselves that they would not invest more than 1 billion euros in the biotechnology sector because of the risks and the patience required.. They ended up exceeding that limit after seeing glimpses of promise. He said, « You want to see your little plants keep growing. ». Their bet on BioNTech sums up their ambition to finance transformative drugs. They helped give the company 150 million euros in seed money in 2008 and now own about half of the company. Its stock surge boosted BioNTech CEO Ugur Shaheen’s fortune to more than $ 4 billion, according to the Bloomberg Index, putting him on the cusp of joining the 500 richest people in the world.. . The Struengmanns family also supported Sahin’s former project, Ganymed Pharmaceuticals AG, a cancer treatment company founded by the Turkish-born scientist with his wife Ozlem Tureci.. Just under a year after the couple turned their attention to Covid-19, the results of the initial trial are confirmation of the new type of drug that they have spent their careers chasing after.. « It could open up the pharmaceutical field to a new class of molecules, » Shaheen said in an interview on Monday.. « Big Elephants » After the brothers took over the Durachemie family-owned pharmaceutical company from their father Ernst in 1979, the brothers sold it seven years later and used the proceeds to create Hexal. They started with about twenty employees in an apartment building near Munich and developed it into the fourth largest generic drug company in the world.. « Our strength is speed and flexibility, » said Thomas, who holds a PhD in Business Administration, in a 2004 interview.. “While the big elephants are making their decisions, we have already taken action. BioNTech’s U. s. The IPO last year culminated in a busy contract for the two brothers. Since 2010, they have invested with EQT AB in a hearing instrument company from Siemens AG, selling German lender Suedwestbank AG for more than double what they paid for in 2004 and taking stakes in several biotech companies including Immatics NV. Which recently merged with Arya Sciences Acquisition Corp.. Not all of their bets paid off. Immatics’ share price has fallen by about a third since it began trading on the Nasdaq in July, while the share price of 4SC AG, the German cancer drug company in which Struengmanns makes up the majority of shareholders, has dropped more than a fifth this year. BioNTech had a tough start, pricing its IPO below its target range, although its shares have since risen 580%.. « For us, it’s not primarily about going back, » Thomas said in an interview with Handelsblatt.. It is, above all, about generating highly effective medical innovations. (Updates with Sahin Company details in the 10th paragraph) For more articles like this one, please visit us at Bloomberg. comSubscribe now to keep up with your most trusted business news source. © 2020 Bloomberg LLC. s.
The number of retired investors with at least $ 1 million saved in their accounts reached a record high in the third quarter, even as the second wave of the pandemic approached and the economic outlook remained uncertain..
The investment ban is the latest attempt by the Trump administration to restrict the flow of capital to Chinese companies.
The value of all tradable stocks in the world rose to surpass the $ 95 trillion barrier for the first time ever this week as the recovery after the elections and before the vaccine continues to boost markets at home and abroad..
Just over a week has passed since the presidential election, and the market’s reaction is showing that investors are happy. While the electoral margins were very weak, came the will of the voters: They rejected Donald Trump and his bold approach to you, but they also rejected the policy of the Democratic Party; The Democrats lost seats in the House of Representatives, and are unlikely to control the Senate, and they have lost ground statewide. American voters seem tired of drama, whether it comes from Donald Trump or the Democrats’ drive to the political left.. They want a government that will simply move steadily. And it looks like they’ll get exactly that. With the power split in the White House and both houses of Congress, we are about to be reminded of the peculiarity of the checks and balances system: This deadlock is the result of a closely divided electorate.. Change will not happen unless one side or the other obtains a large majority, or a small majority over multiple periods. Neither of these is in the cards at the moment. The immediate result is the market rally for several days. The implication is clear – market sentiment has calmed since the elections, and investors are looking for a more normal government stabilization in the coming months.. To that end, investors are sure to find solid options in the near term. Writing analyst Rick Prentice of Raymond James has recently published three reviews on mid-size stocks, citing why, in his opinion, they offer high yield potential with more stable markets in the coming year. All stocks fit into a profile: they are at the lower end of the mid-range corporate range, with market valuations of $ 2 billion to $ 3 billion; They inhabit the communications ecosystem, and they all have, according to Raymond James, 80% higher potential.. We ran all three through the TipRanks database to see what other Wall Street analysts had to say about it. & Telephone Data Systems (TDS) First on our list, & Phone Data Systems Corporation, is a Chicago-based company that provides a range of telecom services to more than 6 million customers.. The company provides broadband services via cable and wire, wireless products and services, TV and audio services. TDS operates the fifth largest cellular carrier in the country. TDS significantly beat expectations in 2020, despite the ongoing coronavirus. Revenue, at a price of $ 1. 32 billion, almost the same level with the pre-Corona report ($ 1. 34 billion in the fourth quarter of 2019), while profits jumped in the first quarter of 2020 and have remained high since then. Third-quarter profit was 66 cents, 153% more than expected.. It was an impressive performance, up 266% year-over-year growth. On another bright note to investors, TDS maintained its dividend payments during the year. The common stock payout of 17 percent annually is 68 cents, and provides a return of 3. 6%, nearly double the average return found among companies listed on S&P. TDS showed strong activity during the year, but its weakness was in the stature of wired fibers and cables. However, Raymond James’s Rick Prentice looks at the half-full glass, noting: “WFH policies have continued to get some slow approvals from municipalities and electrical utilities associated with building the fiber-wind.. In some cases, TDS focus on better-economical alternatives. However, TDS Telecom grew fiber service addresses by 5% year-over-year and is seeing better-than-expected take rates of about 30-40%, depending on the market.. Moreover, 34% of Wireline customers are now served by fiber, compared to 29% a year ago, and TDS expects an acceleration through the rest of 2020.. Prentiss rated the TDS as a solid buy, increasing its target price by 6% to $ 34. At this level, it sees an 81% rally of the stock over the coming months. (To see Prentiss’ track record, click here) This stock also carries a solid buying rating from analyst consensus, based on 3 unanimous buy ratings set in recent weeks.. The shares are priced at $ 18. 73, target average is $ 34. 83 indicates a one-year rise from 85. 5%. (See TDS stock analysis on TipRanks) ViaSat, Inc. (VSAT) Next, ViaSat, is a high-speed satellite broadband provider. The California Corporation serves the commercial and defense markets, based on the broad need, across industries, for secure communications. Social lockdown measures affected the company’s business, especially the airline shutdown. Commercial air traffic relies heavily on satellite communications, and this slowdown continues to put pressure on ViaSat. Headwinds are partly compensated for through an accumulation of required services. Revenue has remained stable over the past four quarters, between $ 530 million and $ 588 million, with the $ 554 million recorded in the third quarter being in the middle of that range.. . Earnings rebounded into positive territory after turning negative in the second quarter. The earnings per share in the third quarter was only 3 cents, but that was a dramatic sequential improvement from the previous net loss of 20 cents.. Looking at the VSAT, Prentice notes, “Government regulations and business networks remain robust, as IFC business continues to weather the significant headwinds related to COVID-19. . . . On the plus side, social distancing and safer home policies are driving more residential broadband data use and pushing ARPUs higher. . . . « Prentiss VSAT rates outperform (i. e. Buy) while its $ 63 Target Price indicates an 87% upside potential. Overall, ViaSat has a moderate buy rating from analyst consensus, based on 3 reviews that include 2 Buy and 1 Hold.. The average target price for stocks is $ 53. 33, which means a 12-month gain of 59% from the $ 33 trading price. 39. (See VSAT Stock Analysis on TipRanks) EchoStar Inc. (SATS) Last but not least, EchoStar, another satellite operator. This company controls a constellation of communications satellites, providing satellite capabilities to the media and private institutions, as well as US government agencies and civilian military.. Additionally, EchoStar provides satellite broadband in 100 countries around the world. On the top line, EchoStar revenue has remained flat over the past three quarters, reaching $ 465 million, $ 459 million, and $ 473 million.. While earnings were negative in the first and second quarters, the third quarter results showed a net profit of 26 cents per share. The Q3 sequential improvements come in the top and bottom lines along with increases in the EchoStar subscriber base, to more than 1. 54 million in total. The company also boasts a strong balance sheet, with over $ 2. 5 billion cash in hand and no net debt. By covering SATS, Ric Prentiss is optimistic about the near and medium term outlook. He writes, “SATS [has] a strategic choice at a time when others, especially leveraged satellite companies, are struggling with a lack of liquidity in the face of large maturities or capital expenditures programs. . . . We believe that a number of options for organic and inorganic growth are being considered, including future deployment of the SBand spectrum after the primary tenant (s) lining up.. Finally, we believe that EchoStar’s recently announced collaboration with Inmarsat to provide capacity for in-flight communication should provide high margin cash flow over time, and note that the deal is not exclusive.. These comments return another strong buying assessment, and Prentiss’ target price of $ 57 indicates a chance of 123% growth next year.. In terms of other analysts’ activity, it was relatively quiet. 1 buy and 1 hold valuations assigned in the past three months add up to the consensus of « moderate buying » analysts. Plus, $ 43. 50 average target price places upside potential at approximately 74%. (See SATS Stock Analysis at TipRanks) To find good stock trading ideas with attractive valuations, visit the Best Stocks to Buy from TipRanks, a newly launched tool that unifies all the stock insights for TipRanks. Disclaimer: The opinions expressed in this article are only those of featured analysts. The content is intended for informational use only. It is very important to do your analysis before making any investment.
General Electric got a boost on Friday after Barclays analyst Julian Mitchell raised the share price target.. The reason behind the analyst’s move is good news for shareholders as well.
Yahoo Finance is in talks with Vice Chairman of Xpeng and President Brian Gu about the Chinese electric car maker’s path forward after its first quarter as a public company..
Pfizer. The candidate coronavirus vaccine (NYSE: PFE) may have produced strong effective results, but the logistics that require it may affect the vaccine uptake in the end.. Opportunity in times of distress: the mRNA vaccine developed by Pfizer and BioNTech SE – ADR (NASDAQ: BNTX) requires a negative storage temperature of 70 ° C. . This poses logistical challenges, especially in poor countries that do not have the infrastructure or cold chain to deal with the vaccine. This obstacle is likely to turn into an opportunity for companies operating along the supply chain. Freeze box manufacturers: Companies such as Carrier Global Corp (NYSE: CARR) and Trane Technologies PLC (NYSE: TT) are the supply chain plays that will benefit from vaccine approval.. Trane Tech’s Thermo King brand provides a smart, temperature-controlled cold chain solution for vaccine shipments. In late September, the company launched cold storage solutions to support the distribution of the COVID-19 vaccine. « Given the urgent global need for the COVID-19 vaccine, the world cannot afford cold chain disruptions, » said Dave Regnery, Operations Director at Trane Technologies.. . Our new cold storage solutions can maintain temperatures of -70 ° C for an extended period of time, and can be leveraged to help reduce pollen degradation, and most importantly, can prevent pollen ‘deserts’ or inaccessibility. « Related link: Startup Democratizes Shipping Brokerage and Carrier Global Funding » announced in early October its collaboration with Amazon. Com, inc. (NASDAQ: AMZN) AWS to participate in the development of the new Lynx digital platform. “This toolkit will provide Carrier customers around the world with improved visibility, increased connectivity, and operational intelligence across their cold chain operations to improve the results of temperature-sensitive shipments, including food, drugs, and vaccines,” release announcement. Thermo Fisher Scientific Company. (NYSE: TMO) manufactures ultra-low temperature freezers that can maintain temperatures of around 80 degrees Celsius. Dry ice manufacturers: Germany’s Linde PLC (NYSE: LIN) and France-based L Air Liquide Ord ADR (OTC: AIQUY) are suppliers of liquid ice, which is nothing but solidified carbon dioxide. While transporting the vaccines, they must be stored under dry ice in thermal containers to maintain their effectiveness. Delivery companies: Pfizer plans to distribute its COVID-19 vaccine in about 12 trucks per day that will launch from its installation and packaging facility in Kalamazoo, Michigan, according to a Supply Chain Dive report, citing an email from a Pfizer spokesperson. The company is said to be planning to use FedEx Corporation (NYSE: FDX), United Parcel Service, Inc. (NYSE: UPS) and DHL to distribute the vaccine throughout the United States. s. Related link: PowerFleet Secures Healthcare Supplies for COVID-19 Across Africa See More From Benzinga * Click Here For Option Deals From Benzinga * 5 Highest Semiconductor Stocks During Post-Election Run * Nio, Li Auto Makes Big Moves Following Xpeng’s third-quarter (C) 2020 results, Benzinga. Com. Benzanga does not provide investment advice. All rights reserved.
LinkedIn co-founder and top Democratic donor Reid Hoffman has warned of a disintegration of the tech giants helping drive U. s. Economy, predicting instead that the number of tech giants will soon double without interference from the federal government.
Norwegian Cruise Line, NYSE: NCLH, New York Stock Exchange, Cruise ship, Carnival Corporation & plc
World News – AU – Earnings Update: Here’s why analysts raised their Norwegian cruise Line Holdings Ltd. (NYSE: NCLH) $ 20 target price. 31
. . Related Title :
– Norwegian Cruise Line& # 39; s Oceania Cruises sets one-day reservation records for the 2022 summer season
– Free launching Norwegian Series Documenting its brand’s journey
– Myovant Sciences Ltd. (NYSE: MYOV) rises 2. 39% in a week – but can it keep rising?
– Norwegian Cruise Line to showcase the brand in an online documentary series
– Norwegian Cruise Line stars in new documentary series
– <a href = "/? s = Norwegian Cruise Line (NYSE: NCLH) It topped the ranking in the 2021 Institutional Investor All-America Executive Team . . . The Norwegian Cruise Line (NYSE: NCLH) topped the rankings in the 2021 Institutional Investor All-America Executive Team . . .
– <a href = "/? s = earnings update: Here& # 39; s Why did analysts just raise Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) Price . . . Earnings update: Here is & # 39; s why analysts just raised Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) Price . . .
– <a href = "/? s = Hotels, Resorts and Cruise Lines Market Segments, Regional and Global Trends, Outlook and Key Players – Marriott . . . Hotel, Resort & Cruise Line Market Sectors, Regional and Global Trends, Outlook and Key Players – Marriott . . .
Donnez votre point de vue et aboonez-vous!
Votre point de vue compte, donnez votre avis
[maxbutton id= »1″]